Pharmaceutical manufacturers of Orlistat

Founded in 1978, Biocon Limited is the largest biotechnology company in India and a leading company in Asia, focusing on biopharmaceuticals and research services. It is an integrated and innovation-driven enterprise that provides affordable solutions for chronic diseases globally. The company develops, manufactures, and offers a diverse portfolio of Small Molecules APIs & Formulations and Complex Biologics, including Novels and Biosimilars like MAbs, rh-insulin& Insulin Analogs. Among its notable products are the world's first Pichia-based recombinant human Insulin, INSUGEN, Glargine, BASALOG, and India's first biologic BioMAb-EGFR for head and neck cancer. Additionally, it has developed Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, introduced as Alzumab for psoriasis in India in 2013.

Founded in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise featuring whole chain, multi-regional integration of research, production and marketing as well as development of drug substances and preparations. In 2000, an A-share was issued in order to enter the stock market as a state-owned listed company. As of 2021, Hisun Pharmaceutical is now one of the largest producers of antibiotics and anti-tumor drugs in China and has been listed in the Top 500 Chinese manufacturing enterprises and the Top 100 Chinese pharmaceutical enterprises multiple times. In 2020 Hisun Pharmaceuticals received special recognition from the Joint Prevention and Control Team from the State Council of the People’s Republic of China for their extraordinary efforts in the fight against the epidemic, and Hisun Pharmaceutical was awarded with the “Anti COVID-19 Advanced Collective in Ministry of Industry and Information Technology".

Formosa Laboratories serves customers globally as a leading supplier of active pharmaceutical ingredients (APIs). They offer a comprehensive range of CDMO services, including the development and production of APIs, ADCs, and cytotoxic and non-cytotoxic injectables using aseptic liquid filling and lyophilization processes. Formosa Laboratories is equipped to provide full-service GMP manufacturing for drug substances, ADCs, and drug products through its API and injectable facilities, which are designed to accommodate small molecules and more.

Lunan Pharma is a prominent pharmaceutical firm dedicated to enhancing human well-being through the production and promotion of top-quality pharmaceutical products. The company achieved total sales revenues of 1.8 billion dollars in 2020 and is ranked among the top 22 in China.

Hanmi has experienced notable expansion since its establishment in 1973 and has emerged as the most prominent company among pharmaceutical firms in South Korea. We take pride in being recognized as a global frontrunner in the production of high-quality API for cephalosporins, cardiovascular, anti-diabetic, gastrointestinal, and CNS medications. The facilities have undergone inspection and received approval from UK MHRA, German BSG, Australian TGA, and US FDA. Hanmi has successfully developed and introduced new combination drugs and a series of IMDs using its patented process

Livzon Group is a full-fledged pharmaceutical company that integrates the advancement and exploration, manufacturing, and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients (API), chemical medication, diagnostic reagents, and more. Recently, Livzon has shifted its strategic focus to research and development in antibody medications and vaccines, and has set up specialized laboratories for this purpose.

Shree Venkatesh International Limited has established itself as a rapidly growing and distinguished Indian company dedicated to the production, promotion, and export of Hormonal products. Our state-of-the-art facility is equipped with advanced technologies specifically designed for a wide range of Gynecological, IVFs, and Contraceptives Hormonal products. At Shree Venkatesh International Limited, we tirelessly strive to develop highly efficient and safe hormonal products and make them accessible at the most competitive prices globally. Our portfolio includes Injectables, lyophilized powder, and hormonal Oral tablets, contributing to the enhancement of reproductive health on a global scale. Our WHO-GMP (India) plant has been inspected and approved by regulatory bodies in Yemen (SBDMA), Kenya (PPB), Nigeria (NAFDAC), Cambodia, and the Philippines. We have plans to extend our product reach to countries in the CIS, African, Southern Asian, Southern American, PIC/s, and MENA regions. For further information, please visit www.shreevenkatesh.com. Shree Venkatesh International Limited is an ISO9001:2008 Certified company registered under the Registrar of Companies Act, specializing in the export of Generic Medicines, Pharmaceutical formulations, and Bulk drugs from India. The company is based in Gujarat, which is renowned as the Manufacturing Hub for Pharmaceutical formulations in India.

Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd (FFPC) was founded in 1979. Livzon Pharmaceutical Group Inc purchased FFPC in 2004, aiming to transform it into a top-notch API production center and R&D center. FFPC is a sizable pharmaceutical company with two facilities, Gutian Fuxing Pharmaceutical Co., Ltd and Fuqing Jiangyin site. FFPC has state-of-the-art machinery and advanced technology.

Established in 2004, Murli Krishna Pharma Pvt Ltd is a youthful and dynamic organization specializing in Novel Drug Delivery Systems (NDDS). It offers a variety of effective solutions for enhancing the delivery of pharmaceutical products. The current operations involve the production of pre-finished formulations such as Pellets, Granules, and MUPS using Aqueous Based technology, Nano Particles, and Transdermal Oil. The facility is furnished with state-of-the-art machinery and 21 CFR, part 11 compliant instruments.

We, Precise Biopharma Pvt, seek your assistance in developing our product for the market in IRAQ. We, M/s Precise Chemipharma Pvt.Ltd, would like to present ourselves as one of the foremost Manufacturers and Exporters of Active Pharmaceutical Ingredients (API’s), Intermediates, Drug Pellets & Finished Dosage Forms

Since our inception in 2006, Titan Laboratories has focused on formulating new-age solutions in diversified spectrums of Pellets, Granules, Tablets and Capsule manufacturing. With the expertise of such widespread specialties, we at Titan Laboratories take great pride in our proficiency in providing Quality Analytical Services that focus on the formulation & packaging of both solid and semi-solid finished products. Backed by our holistic approach towards catering to multifarious integrated services, we aim to meet the concept-to-commercialization needs of our customers while providing quality pellets, granules or finish formulations.

PHT International provides comprehensive global solutions for contract research and production to partners in the pharmaceutical, agrochemical, and specialty chemical sectors. Leveraging worldwide sourcing capabilities and cutting-edge process development and cGMP manufacturing, PHT delivers a full range of services in development chemistry, analytical development, advanced intermediate manufacturing, RSM, and API manufacturing at our FDA-inspected facilities. No matter the scope of your project, our team offers more than 28 years of international expertise to ensure your success. GPT Pharmaceuticals Pvt. Ltd was founded in 2009 by a group of professionals with extensive experience in the pharmaceutical industry, specializing in the development and production of Pharmaceutical Formulation Intermediates (PFIs) and various modified release oral dosage forms using advanced Drug Delivery Systems based on polymers. Controlled drug delivery technology is a rapidly advancing area of science that significantly contributes to human healthcare. These delivery systems present numerous advantages over conventional dosage forms, including enhanced efficacy, reduced toxicity, and improved patient compliance. LP Pharmaceutical (Xiamen) Co., Ltd., situated in Xiamen Biomedical Industry Base, formulates and manufactures pharmaceuticals with enhanced delivery properties. Established in 2012 by a team of scientists and business experts with extensive backgrounds in the pharmaceutical industries of the United States and China, the company's proprietary delivery platforms encompass mucosal and oral controlled release. The current therapeutic areas of focus include the central nervous system, digestive system, cardiovascular health, cancer, and AIDS.

Established in 2001, Zein Biotechnology Co., Ltd. is a high-tech firm on a national level that focuses on developing a comprehensive management system for pharmaceuticals throughout their entire lifecycle. The company's primary focus is on supporting the registration and commercialization of MAH (Marketing Authorization Holder) drugs, as well as ensuring compliance management and providing key technical services for drug development, manufacturing, transaction promotion, and post-marketing drug studies.